Global Squamous Non-Small Cell Lung Cancer Therapeutics Market Size, Status and Forecast 2021-2027

Global Squamous Non-Small Cell Lung Cancer Therapeutics Market Size, Status and Forecast 2021-2027

Table of Contents
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Squamous Non-Small Cell Lung Cancer Therapeutics Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
1.2.2 BMS-906024
1.2.3 Buparlisib Hydrochloride
1.2.4 FP-1039
1.2.5 Ipilimumab
1.2.6 JNJ-42756493
1.2.7 Lenvatinib
1.2.8 Others
1.3 Market by Application
1.3.1 Global Squamous Non-Small Cell Lung Cancer Therapeutics Market Share by Application: 2016 VS 2021 VS 2027
1.3.2 Research Center
1.3.3 Hospital
1.3.4 Clinic
1.4 Study Objectives
1.5 Years Considered
2 Global Growth Trends
2.1 Global Squamous Non-Small Cell Lung Cancer Therapeutics Market Perspective (2016-2027)
2.2 Squamous Non-Small Cell Lung Cancer Therapeutics Growth Trends by Regions
2.2.1 Squamous Non-Small Cell Lung Cancer Therapeutics Market Size by Regions: 2016 VS 2021 VS 2027
2.2.2 Squamous Non-Small Cell Lung Cancer Therapeutics Historic Market Share by Regions (2016-2021)
2.2.3 Squamous Non-Small Cell Lung Cancer Therapeutics Forecasted Market Size by Regions (2022-2027)
2.3 Squamous Non-Small Cell Lung Cancer Therapeutics Industry Dynamic
2.3.1 Squamous Non-Small Cell Lung Cancer Therapeutics Market Trends
2.3.2 Squamous Non-Small Cell Lung Cancer Therapeutics Market Drivers
2.3.3 Squamous Non-Small Cell Lung Cancer Therapeutics Market Challenges
2.3.4 Squamous Non-Small Cell Lung Cancer Therapeutics Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Squamous Non-Small Cell Lung Cancer Therapeutics Players by Revenue
3.1.1 Global Top Squamous Non-Small Cell Lung Cancer Therapeutics Players by Revenue (2016-2021)
3.1.2 Global Squamous Non-Small Cell Lung Cancer Therapeutics Revenue Market Share by Players (2016-2021)
3.2 Global Squamous Non-Small Cell Lung Cancer Therapeutics Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Players Covered: Ranking by Squamous Non-Small Cell Lung Cancer Therapeutics Revenue
3.4 Global Squamous Non-Small Cell Lung Cancer Therapeutics Market Concentration Ratio
3.4.1 Global Squamous Non-Small Cell Lung Cancer Therapeutics Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Squamous Non-Small Cell Lung Cancer Therapeutics Revenue in 2020
3.5 Squamous Non-Small Cell Lung Cancer Therapeutics Key Players Head office and Area Served
3.6 Key Players Squamous Non-Small Cell Lung Cancer Therapeutics Product Solution and Service
3.7 Date of Enter into Squamous Non-Small Cell Lung Cancer Therapeutics Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Squamous Non-Small Cell Lung Cancer Therapeutics Breakdown Data by Type
4.1 Global Squamous Non-Small Cell Lung Cancer Therapeutics Historic Market Size by Type (2016-2021)
4.2 Global Squamous Non-Small Cell Lung Cancer Therapeutics Forecasted Market Size by Type (2022-2027)
5 Squamous Non-Small Cell Lung Cancer Therapeutics Breakdown Data by Application
5.1 Global Squamous Non-Small Cell Lung Cancer Therapeutics Historic Market Size by Application (2016-2021)
5.2 Global Squamous Non-Small Cell Lung Cancer Therapeutics Forecasted Market Size by Application (2022-2027)
6 North America
6.1 North America Squamous Non-Small Cell Lung Cancer Therapeutics Market Size (2016-2027)
6.2 North America Squamous Non-Small Cell Lung Cancer Therapeutics Market Size by Type
6.2.1 North America Squamous Non-Small Cell Lung Cancer Therapeutics Market Size by Type (2016-2021)
6.2.2 North America Squamous Non-Small Cell Lung Cancer Therapeutics Market Size by Type (2022-2027)
6.2.3 North America Squamous Non-Small Cell Lung Cancer Therapeutics Market Size by Type (2016-2027)
6.3 North America Squamous Non-Small Cell Lung Cancer Therapeutics Market Size by Application
6.3.1 North America Squamous Non-Small Cell Lung Cancer Therapeutics Market Size by Application (2016-2021)
6.3.2 North America Squamous Non-Small Cell Lung Cancer Therapeutics Market Size by Application (2022-2027)
6.3.3 North America Squamous Non-Small Cell Lung Cancer Therapeutics Market Size by Application (2016-2027)
6.4 North America Squamous Non-Small Cell Lung Cancer Therapeutics Market Size by Country
6.4.1 North America Squamous Non-Small Cell Lung Cancer Therapeutics Market Size by Country (2016-2021)
6.4.2 North America Squamous Non-Small Cell Lung Cancer Therapeutics Market Size by Country (2022-2027)
6.4.3 United States
6.4.4 Canada
7 Europe
7.1 Europe Squamous Non-Small Cell Lung Cancer Therapeutics Market Size (2016-2027)
7.2 Europe Squamous Non-Small Cell Lung Cancer Therapeutics Market Size by Type
7.2.1 Europe Squamous Non-Small Cell Lung Cancer Therapeutics Market Size by Type (2016-2021)
7.2.2 Europe Squamous Non-Small Cell Lung Cancer Therapeutics Market Size by Type (2022-2027)
7.2.3 Europe Squamous Non-Small Cell Lung Cancer Therapeutics Market Size by Type (2016-2027)
7.3 Europe Squamous Non-Small Cell Lung Cancer Therapeutics Market Size by Application
7.3.1 Europe Squamous Non-Small Cell Lung Cancer Therapeutics Market Size by Application (2016-2021)
7.3.2 Europe Squamous Non-Small Cell Lung Cancer Therapeutics Market Size by Application (2022-2027)
7.3.3 Europe Squamous Non-Small Cell Lung Cancer Therapeutics Market Size by Application (2016-2027)
7.4 Europe Squamous Non-Small Cell Lung Cancer Therapeutics Market Size by Country
7.4.1 Europe Squamous Non-Small Cell Lung Cancer Therapeutics Market Size by Country (2016-2021)
7.4.2 Europe Squamous Non-Small Cell Lung Cancer Therapeutics Market Size by Country (2022-2027)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic
8 Asia-Pacific
8.1 Asia-Pacific Squamous Non-Small Cell Lung Cancer Therapeutics Market Size (2016-2027)
8.2 Asia-Pacific Squamous Non-Small Cell Lung Cancer Therapeutics Market Size by Type
8.2.1 Asia-Pacific Squamous Non-Small Cell Lung Cancer Therapeutics Market Size by Type (2016-2021)
8.2.2 Asia-Pacific Squamous Non-Small Cell Lung Cancer Therapeutics Market Size by Type (2022-2027)
8.2.3 Asia-Pacific Squamous Non-Small Cell Lung Cancer Therapeutics Market Size by Type (2016-2027)
8.3 Asia-Pacific Squamous Non-Small Cell Lung Cancer Therapeutics Market Size by Application
8.3.1 Asia-Pacific Squamous Non-Small Cell Lung Cancer Therapeutics Market Size by Application (2016-2021)
8.3.2 Asia-Pacific Squamous Non-Small Cell Lung Cancer Therapeutics Market Size by Application (2022-2027)
8.3.3 Asia-Pacific Squamous Non-Small Cell Lung Cancer Therapeutics Market Size by Application (2016-2027)
8.4 Asia-Pacific Squamous Non-Small Cell Lung Cancer Therapeutics Market Size by Region
8.4.1 Asia-Pacific Squamous Non-Small Cell Lung Cancer Therapeutics Market Size by Region (2016-2021)
8.4.2 Asia-Pacific Squamous Non-Small Cell Lung Cancer Therapeutics Market Size by Region (2022-2027)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia
9 Latin America
9.1 Latin America Squamous Non-Small Cell Lung Cancer Therapeutics Market Size (2016-2027)
9.2 Latin America Squamous Non-Small Cell Lung Cancer Therapeutics Market Size by Type
9.2.1 Latin America Squamous Non-Small Cell Lung Cancer Therapeutics Market Size by Type (2016-2021)
9.2.2 Latin America Squamous Non-Small Cell Lung Cancer Therapeutics Market Size by Type (2022-2027)
9.2.3 Latin America Squamous Non-Small Cell Lung Cancer Therapeutics Market Size by Type (2016-2027)
9.3 Latin America Squamous Non-Small Cell Lung Cancer Therapeutics Market Size by Application
9.3.1 Latin America Squamous Non-Small Cell Lung Cancer Therapeutics Market Size by Application (2016-2021)
9.3.2 Latin America Squamous Non-Small Cell Lung Cancer Therapeutics Market Size by Application (2022-2027)
9.3.3 Latin America Squamous Non-Small Cell Lung Cancer Therapeutics Market Size by Application (2016-2027)
9.4 Latin America Squamous Non-Small Cell Lung Cancer Therapeutics Market Size by Country
9.4.1 Latin America Squamous Non-Small Cell Lung Cancer Therapeutics Market Size by Country (2016-2021)
9.4.2 Latin America Squamous Non-Small Cell Lung Cancer Therapeutics Market Size by Country (2022-2027)
9.4.3 Mexico
9.4.4 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Squamous Non-Small Cell Lung Cancer Therapeutics Market Size (2016-2027)
10.2 Middle East & Africa Squamous Non-Small Cell Lung Cancer Therapeutics Market Size by Type
10.2.1 Middle East & Africa Squamous Non-Small Cell Lung Cancer Therapeutics Market Size by Type (2016-2021)
10.2.2 Middle East & Africa Squamous Non-Small Cell Lung Cancer Therapeutics Market Size by Type (2022-2027)
10.2.3 Middle East & Africa Squamous Non-Small Cell Lung Cancer Therapeutics Market Size by Type (2016-2027)
10.3 Middle East & Africa Squamous Non-Small Cell Lung Cancer Therapeutics Market Size by Application
10.3.1 Middle East & Africa Squamous Non-Small Cell Lung Cancer Therapeutics Market Size by Application (2016-2021)
10.3.2 Middle East & Africa Squamous Non-Small Cell Lung Cancer Therapeutics Market Size by Application (2022-2027)
10.3.3 Middle East & Africa Squamous Non-Small Cell Lung Cancer Therapeutics Market Size by Application (2016-2027)
10.4 Middle East & Africa Squamous Non-Small Cell Lung Cancer Therapeutics Market Size by Country
10.4.1 Middle East & Africa Squamous Non-Small Cell Lung Cancer Therapeutics Market Size by Country (2016-2021)
10.4.2 Middle East & Africa Squamous Non-Small Cell Lung Cancer Therapeutics Market Size by Country (2022-2027)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE
11 Key Players Profiles
11.1 Ascenta Therapeutics, Inc.
11.1.1 Ascenta Therapeutics, Inc. Company Details
11.1.2 Ascenta Therapeutics, Inc. Business Overview
11.1.3 Ascenta Therapeutics, Inc. Squamous Non-Small Cell Lung Cancer Therapeutics Introduction
11.1.4 Ascenta Therapeutics, Inc. Revenue in Squamous Non-Small Cell Lung Cancer Therapeutics Business (2016-2021)
11.1.5 Ascenta Therapeutics, Inc. Recent Development
11.2 AstraZeneca Plc
11.2.1 AstraZeneca Plc Company Details
11.2.2 AstraZeneca Plc Business Overview
11.2.3 AstraZeneca Plc Squamous Non-Small Cell Lung Cancer Therapeutics Introduction
11.2.4 AstraZeneca Plc Revenue in Squamous Non-Small Cell Lung Cancer Therapeutics Business (2016-2021)
11.2.5 AstraZeneca Plc Recent Development
11.3 AVEO Pharmaceuticals, Inc.
11.3.1 AVEO Pharmaceuticals, Inc. Company Details
11.3.2 AVEO Pharmaceuticals, Inc. Business Overview
11.3.3 AVEO Pharmaceuticals, Inc. Squamous Non-Small Cell Lung Cancer Therapeutics Introduction
11.3.4 AVEO Pharmaceuticals, Inc. Revenue in Squamous Non-Small Cell Lung Cancer Therapeutics Business (2016-2021)
11.3.5 AVEO Pharmaceuticals, Inc. Recent Development
11.4 Bayer AG
11.4.1 Bayer AG Company Details
11.4.2 Bayer AG Business Overview
11.4.3 Bayer AG Squamous Non-Small Cell Lung Cancer Therapeutics Introduction
11.4.4 Bayer AG Revenue in Squamous Non-Small Cell Lung Cancer Therapeutics Business (2016-2021)
11.4.5 Bayer AG Recent Development
11.5 BIND Therapeutics, Inc.
11.5.1 BIND Therapeutics, Inc. Company Details
11.5.2 BIND Therapeutics, Inc. Business Overview
11.5.3 BIND Therapeutics, Inc. Squamous Non-Small Cell Lung Cancer Therapeutics Introduction
11.5.4 BIND Therapeutics, Inc. Revenue in Squamous Non-Small Cell Lung Cancer Therapeutics Business (2016-2021)
11.5.5 BIND Therapeutics, Inc. Recent Development
11.6 Boehringer Ingelheim GmbH
11.6.1 Boehringer Ingelheim GmbH Company Details
11.6.2 Boehringer Ingelheim GmbH Business Overview
11.6.3 Boehringer Ingelheim GmbH Squamous Non-Small Cell Lung Cancer Therapeutics Introduction
11.6.4 Boehringer Ingelheim GmbH Revenue in Squamous Non-Small Cell Lung Cancer Therapeutics Business (2016-2021)
11.6.5 Boehringer Ingelheim GmbH Recent Development
11.7 Bristol-Myers Squibb Company
11.7.1 Bristol-Myers Squibb Company Company Details
11.7.2 Bristol-Myers Squibb Company Business Overview
11.7.3 Bristol-Myers Squibb Company Squamous Non-Small Cell Lung Cancer Therapeutics Introduction
11.7.4 Bristol-Myers Squibb Company Revenue in Squamous Non-Small Cell Lung Cancer Therapeutics Business (2016-2021)
11.7.5 Bristol-Myers Squibb Company Recent Development
11.8 Eli Lilly and Company
11.8.1 Eli Lilly and Company Company Details
11.8.2 Eli Lilly and Company Business Overview
11.8.3 Eli Lilly and Company Squamous Non-Small Cell Lung Cancer Therapeutics Introduction
11.8.4 Eli Lilly and Company Revenue in Squamous Non-Small Cell Lung Cancer Therapeutics Business (2016-2021)
11.8.5 Eli Lilly and Company Recent Development
11.9 F. Hoffmann-La Roche Ltd.
11.9.1 F. Hoffmann-La Roche Ltd. Company Details
11.9.2 F. Hoffmann-La Roche Ltd. Business Overview
11.9.3 F. Hoffmann-La Roche Ltd. Squamous Non-Small Cell Lung Cancer Therapeutics Introduction
11.9.4 F. Hoffmann-La Roche Ltd. Revenue in Squamous Non-Small Cell Lung Cancer Therapeutics Business (2016-2021)
11.9.5 F. Hoffmann-La Roche Ltd. Recent Development
11.10 Five Prime Therapeutics, Inc.
11.10.1 Five Prime Therapeutics, Inc. Company Details
11.10.2 Five Prime Therapeutics, Inc. Business Overview
11.10.3 Five Prime Therapeutics, Inc. Squamous Non-Small Cell Lung Cancer Therapeutics Introduction
11.10.4 Five Prime Therapeutics, Inc. Revenue in Squamous Non-Small Cell Lung Cancer Therapeutics Business (2016-2021)
11.10.5 Five Prime Therapeutics, Inc. Recent Development
11.11 Genentech, Inc.
11.11.1 Genentech, Inc. Company Details
11.11.2 Genentech, Inc. Business Overview
11.11.3 Genentech, Inc. Squamous Non-Small Cell Lung Cancer Therapeutics Introduction
11.11.4 Genentech, Inc. Revenue in Squamous Non-Small Cell Lung Cancer Therapeutics Business (2016-2021)
11.11.5 Genentech, Inc. Recent Development
11.12 Incyte Corporation
11.12.1 Incyte Corporation Company Details
11.12.2 Incyte Corporation Business Overview
11.12.3 Incyte Corporation Squamous Non-Small Cell Lung Cancer Therapeutics Introduction
11.12.4 Incyte Corporation Revenue in Squamous Non-Small Cell Lung Cancer Therapeutics Business (2016-2021)
11.12.5 Incyte Corporation Recent Development
11.13 Johnson & Johnson
11.13.1 Johnson & Johnson Company Details
11.13.2 Johnson & Johnson Business Overview
11.13.3 Johnson & Johnson Squamous Non-Small Cell Lung Cancer Therapeutics Introduction
11.13.4 Johnson & Johnson Revenue in Squamous Non-Small Cell Lung Cancer Therapeutics Business (2016-2021)
11.13.5 Johnson & Johnson Recent Development
11.14 MacroGenics, Inc.
11.14.1 MacroGenics, Inc. Company Details
11.14.2 MacroGenics, Inc. Business Overview
11.14.3 MacroGenics, Inc. Squamous Non-Small Cell Lung Cancer Therapeutics Introduction
11.14.4 MacroGenics, Inc. Revenue in Squamous Non-Small Cell Lung Cancer Therapeutics Business (2016-2021)
11.14.5 MacroGenics, Inc. Recent Development
11.15 Novartis AG
11.15.1 Novartis AG Company Details
11.15.2 Novartis AG Business Overview
11.15.3 Novartis AG Squamous Non-Small Cell Lung Cancer Therapeutics Introduction
11.15.4 Novartis AG Revenue in Squamous Non-Small Cell Lung Cancer Therapeutics Business (2016-2021)
11.15.5 Novartis AG Recent Development
11.16 Oncogenex Pharmaceuticals, Inc.
11.16.1 Oncogenex Pharmaceuticals, Inc. Company Details
11.16.2 Oncogenex Pharmaceuticals, Inc. Business Overview
11.16.3 Oncogenex Pharmaceuticals, Inc. Squamous Non-Small Cell Lung Cancer Therapeutics Introduction
11.16.4 Oncogenex Pharmaceuticals, Inc. Revenue in Squamous Non-Small Cell Lung Cancer Therapeutics Business (2016-2021)
11.16.5 Oncogenex Pharmaceuticals, Inc. Recent Development
11.17 PsiOxus Therapeutics Limited
11.17.1 PsiOxus Therapeutics Limited Company Details
11.17.2 PsiOxus Therapeutics Limited Business Overview
11.17.3 PsiOxus Therapeutics Limited Squamous Non-Small Cell Lung Cancer Therapeutics Introduction
11.17.4 PsiOxus Therapeutics Limited Revenue in Squamous Non-Small Cell Lung Cancer Therapeutics Business (2016-2021)
11.17.5 PsiOxus Therapeutics Limited Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
List of Tables
Table 1. Global Squamous Non-Small Cell Lung Cancer Therapeutics Market Size Growth Rate by Type (US$ Million):2016 VS 2021 VS 2027
Table 2. Key Players of BMS-906024
Table 3. Key Players of Buparlisib Hydrochloride
Table 4. Key Players of FP-1039
Table 5. Key Players of Ipilimumab
Table 6. Key Players of JNJ-42756493
Table 7. Key Players of Lenvatinib
Table 8. Key Players of Others
Table 9. Global Squamous Non-Small Cell Lung Cancer Therapeutics Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027
Table 10. Global Squamous Non-Small Cell Lung Cancer Therapeutics Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027
Table 11. Global Squamous Non-Small Cell Lung Cancer Therapeutics Market Size by Regions (2016-2021) & (US$ Million)
Table 12. Global Squamous Non-Small Cell Lung Cancer Therapeutics Market Share by Regions (2016-2021)
Table 13. Global Squamous Non-Small Cell Lung Cancer Therapeutics Forecasted Market Size by Regions (2022-2027) & (US$ Million)
Table 14. Global Squamous Non-Small Cell Lung Cancer Therapeutics Market Share by Regions (2022-2027)
Table 15. Squamous Non-Small Cell Lung Cancer Therapeutics Market Trends
Table 16. Squamous Non-Small Cell Lung Cancer Therapeutics Market Drivers
Table 17. Squamous Non-Small Cell Lung Cancer Therapeutics Market Challenges
Table 18. Squamous Non-Small Cell Lung Cancer Therapeutics Market Restraints
Table 19. Global Squamous Non-Small Cell Lung Cancer Therapeutics Revenue by Players (2016-2021) & (US$ Million)
Table 20. Global Squamous Non-Small Cell Lung Cancer Therapeutics Market Share by Players (2016-2021)
Table 21. Global Top Squamous Non-Small Cell Lung Cancer Therapeutics Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Squamous Non-Small Cell Lung Cancer Therapeutics as of 2020)
Table 22. Ranking of Global Top Squamous Non-Small Cell Lung Cancer Therapeutics Companies by Revenue (US$ Million) in 2020
Table 23. Global 5 Largest Players Market Share by Squamous Non-Small Cell Lung Cancer Therapeutics Revenue (CR5 and HHI) & (2016-2021)
Table 24. Key Players Headquarters and Area Served
Table 25. Key Players Squamous Non-Small Cell Lung Cancer Therapeutics Product Solution and Service
Table 26. Date of Enter into Squamous Non-Small Cell Lung Cancer Therapeutics Market
Table 27. Mergers & Acquisitions, Expansion Plans
Table 28. Global Squamous Non-Small Cell Lung Cancer Therapeutics Market Size by Type (2016-2021) (US$ Million)
Table 29. Global Squamous Non-Small Cell Lung Cancer Therapeutics Revenue Market Share by Type (2016-2021)
Table 30. Global Squamous Non-Small Cell Lung Cancer Therapeutics Forecasted Market Size by Type (2022-2027) (US$ Million)
Table 31. Global Squamous Non-Small Cell Lung Cancer Therapeutics Revenue Market Share by Type (2022-2027) & (US$ Million)
Table 32. Global Squamous Non-Small Cell Lung Cancer Therapeutics Market Size Share by Application (2016-2021) & (US$ Million)
Table 33. Global Squamous Non-Small Cell Lung Cancer Therapeutics Revenue Market Share by Application (2016-2021)
Table 34. Global Squamous Non-Small Cell Lung Cancer Therapeutics Forecasted Market Size by Application (2022-2027) (US$ Million)
Table 35. Global Squamous Non-Small Cell Lung Cancer Therapeutics Revenue Market Share by Application (2022-2027) & (US$ Million)
Table 36. North America Squamous Non-Small Cell Lung Cancer Therapeutics Market Size by Type (2016-2021) (US$ Million)
Table 37. North America Squamous Non-Small Cell Lung Cancer Therapeutics Market Size by Type (2022-2027) & (US$ Million)
Table 38. North America Squamous Non-Small Cell Lung Cancer Therapeutics Market Size by Application (2016-2021) (US$ Million)
Table 39. North America Squamous Non-Small Cell Lung Cancer Therapeutics Market Size by Application (2022-2027) & (US$ Million)
Table 40. North America Squamous Non-Small Cell Lung Cancer Therapeutics Market Size by Country (2016-2021) & (US$ Million)
Table 41. North America Squamous Non-Small Cell Lung Cancer Therapeutics Market Size by Country (2022-2027) & (US$ Million)
Table 42. Europe Squamous Non-Small Cell Lung Cancer Therapeutics Market Size by Type (2016-2021) (US$ Million)
Table 43. Europe Squamous Non-Small Cell Lung Cancer Therapeutics Market Size by Type (2022-2027) & (US$ Million)
Table 44. Europe Squamous Non-Small Cell Lung Cancer Therapeutics Market Size by Application (2016-2021) (US$ Million)
Table 45. Europe Squamous Non-Small Cell Lung Cancer Therapeutics Market Size by Application (2022-2027) & (US$ Million)
Table 46. Europe Squamous Non-Small Cell Lung Cancer Therapeutics Market Size by Country (2016-2021) & (US$ Million)
Table 47. Europe Squamous Non-Small Cell Lung Cancer Therapeutics Market Size by Country (2022-2027) & (US$ Million)
Table 48. Asia-Pacific Squamous Non-Small Cell Lung Cancer Therapeutics Market Size by Type (2016-2021) (US$ Million)
Table 49. Asia-Pacific Squamous Non-Small Cell Lung Cancer Therapeutics Market Size by Type (2022-2027) & (US$ Million)
Table 50. Asia-Pacific Squamous Non-Small Cell Lung Cancer Therapeutics Market Size by Application (2016-2021) (US$ Million)
Table 51. Asia-Pacific Squamous Non-Small Cell Lung Cancer Therapeutics Market Size by Application (2022-2027) & (US$ Million)
Table 52. Asia-Pacific Squamous Non-Small Cell Lung Cancer Therapeutics Market Size by Region (2016-2021) & (US$ Million)
Table 53. Asia-Pacific Squamous Non-Small Cell Lung Cancer Therapeutics Market Size by Region (2022-2027) & (US$ Million)
Table 54. Latin America Squamous Non-Small Cell Lung Cancer Therapeutics Market Size by Type (2016-2021) (US$ Million)
Table 55. Latin America Squamous Non-Small Cell Lung Cancer Therapeutics Market Size by Type (2022-2027) & (US$ Million)
Table 56. Latin America Squamous Non-Small Cell Lung Cancer Therapeutics Market Size by Application (2016-2021) (US$ Million)
Table 57. Latin America Squamous Non-Small Cell Lung Cancer Therapeutics Market Size by Application (2022-2027) & (US$ Million)
Table 58. Latin America Squamous Non-Small Cell Lung Cancer Therapeutics Market Size by Country (2016-2021) & (US$ Million)
Table 59. Latin America Squamous Non-Small Cell Lung Cancer Therapeutics Market Size by Country (2022-2027) & (US$ Million)
Table 60. Middle East & Africa Squamous Non-Small Cell Lung Cancer Therapeutics Market Size by Type (2016-2021) (US$ Million)
Table 61. Middle East & Africa Squamous Non-Small Cell Lung Cancer Therapeutics Market Size by Type (2022-2027) & (US$ Million)
Table 62. Middle East & Africa Squamous Non-Small Cell Lung Cancer Therapeutics Market Size by Application (2016-2021) (US$ Million)
Table 63. Middle East & Africa Squamous Non-Small Cell Lung Cancer Therapeutics Market Size by Application (2022-2027) & (US$ Million)
Table 64. Middle East & Africa Squamous Non-Small Cell Lung Cancer Therapeutics Market Size by Country (2016-2021) & (US$ Million)
Table 65. Middle East & Africa Squamous Non-Small Cell Lung Cancer Therapeutics Market Size by Country (2022-2027) & (US$ Million)
Table 66. Ascenta Therapeutics, Inc. Company Details
Table 67. Ascenta Therapeutics, Inc. Business Overview
Table 68. Ascenta Therapeutics, Inc. Squamous Non-Small Cell Lung Cancer Therapeutics Product
Table 69. Ascenta Therapeutics, Inc. Revenue in Squamous Non-Small Cell Lung Cancer Therapeutics Business (2016-2021) & (US$ Million)
Table 70. Ascenta Therapeutics, Inc. Recent Development
Table 71. AstraZeneca Plc Company Details
Table 72. AstraZeneca Plc Business Overview
Table 73. AstraZeneca Plc Squamous Non-Small Cell Lung Cancer Therapeutics Product
Table 74. AstraZeneca Plc Revenue in Squamous Non-Small Cell Lung Cancer Therapeutics Business (2016-2021) & (US$ Million)
Table 75. AstraZeneca Plc Recent Development
Table 76. AVEO Pharmaceuticals, Inc. Company Details
Table 77. AVEO Pharmaceuticals, Inc. Business Overview
Table 78. AVEO Pharmaceuticals, Inc. Squamous Non-Small Cell Lung Cancer Therapeutics Product
Table 79. AVEO Pharmaceuticals, Inc. Revenue in Squamous Non-Small Cell Lung Cancer Therapeutics Business (2016-2021) & (US$ Million)
Table 80. AVEO Pharmaceuticals, Inc. Recent Development
Table 81. Bayer AG Company Details
Table 82. Bayer AG Business Overview
Table 83. Bayer AG Squamous Non-Small Cell Lung Cancer Therapeutics Product
Table 84. Bayer AG Revenue in Squamous Non-Small Cell Lung Cancer Therapeutics Business (2016-2021) & (US$ Million)
Table 85. Bayer AG Recent Development
Table 86. BIND Therapeutics, Inc. Company Details
Table 87. BIND Therapeutics, Inc. Business Overview
Table 88. BIND Therapeutics, Inc. Squamous Non-Small Cell Lung Cancer Therapeutics Product
Table 89. BIND Therapeutics, Inc. Revenue in Squamous Non-Small Cell Lung Cancer Therapeutics Business (2016-2021) & (US$ Million)
Table 90. BIND Therapeutics, Inc. Recent Development
Table 91. Boehringer Ingelheim GmbH Company Details
Table 92. Boehringer Ingelheim GmbH Business Overview
Table 93. Boehringer Ingelheim GmbH Squamous Non-Small Cell Lung Cancer Therapeutics Product
Table 94. Boehringer Ingelheim GmbH Revenue in Squamous Non-Small Cell Lung Cancer Therapeutics Business (2016-2021) & (US$ Million)
Table 95. Boehringer Ingelheim GmbH Recent Development
Table 96. Bristol-Myers Squibb Company Company Details
Table 97. Bristol-Myers Squibb Company Business Overview
Table 98. Bristol-Myers Squibb Company Squamous Non-Small Cell Lung Cancer Therapeutics Product
Table 99. Bristol-Myers Squibb Company Revenue in Squamous Non-Small Cell Lung Cancer Therapeutics Business (2016-2021) & (US$ Million)
Table 100. Bristol-Myers Squibb Company Recent Development
Table 101. Eli Lilly and Company Company Details
Table 102. Eli Lilly and Company Business Overview
Table 103. Eli Lilly and Company Revenue in Squamous Non-Small Cell Lung Cancer Therapeutics Business (2016-2021) & (US$ Million)
Table 104. Eli Lilly and Company Recent Development
Table 105. F. Hoffmann-La Roche Ltd. Company Details
Table 106. F. Hoffmann-La Roche Ltd. Business Overview
Table 107. F. Hoffmann-La Roche Ltd. Squamous Non-Small Cell Lung Cancer Therapeutics Product
Table 108. F. Hoffmann-La Roche Ltd. Revenue in Squamous Non-Small Cell Lung Cancer Therapeutics Business (2016-2021) & (US$ Million)
Table 109. F. Hoffmann-La Roche Ltd. Recent Development
Table 110. Five Prime Therapeutics, Inc. Company Details
Table 111. Five Prime Therapeutics, Inc. Business Overview
Table 112. Five Prime Therapeutics, Inc. Squamous Non-Small Cell Lung Cancer Therapeutics Product
Table 113. Five Prime Therapeutics, Inc. Revenue in Squamous Non-Small Cell Lung Cancer Therapeutics Business (2016-2021) & (US$ Million)
Table 114. Five Prime Therapeutics, Inc. Recent Development
Table 115. Genentech, Inc. Company Details
Table 116. Genentech, Inc. Business Overview
Table 117. Genentech, Inc. Squamous Non-Small Cell Lung Cancer Therapeutics Product
Table 118. Genentech, Inc. Revenue in Squamous Non-Small Cell Lung Cancer Therapeutics Business (2016-2021) & (US$ Million)
Table 119. Genentech, Inc. Recent Development
Table 120. Incyte Corporation Company Details
Table 121. Incyte Corporation Business Overview
Table 122. Incyte Corporation Squamous Non-Small Cell Lung Cancer Therapeutics Product
Table 123. Incyte Corporation Revenue in Squamous Non-Small Cell Lung Cancer Therapeutics Business (2016-2021) & (US$ Million)
Table 124. Incyte Corporation Recent Development
Table 125. Johnson & Johnson Company Details
Table 126. Johnson & Johnson Business Overview
Table 127. Johnson & Johnson Squamous Non-Small Cell Lung Cancer Therapeutics Product
Table 128. Johnson & Johnson Revenue in Squamous Non-Small Cell Lung Cancer Therapeutics Business (2016-2021) & (US$ Million)
Table 129. Johnson & Johnson Recent Development
Table 130. MacroGenics, Inc. Company Details
Table 131. MacroGenics, Inc. Business Overview
Table 132. MacroGenics, Inc. Squamous Non-Small Cell Lung Cancer Therapeutics Product
Table 133. MacroGenics, Inc. Revenue in Squamous Non-Small Cell Lung Cancer Therapeutics Business (2016-2021) & (US$ Million)
Table 134. MacroGenics, Inc. Recent Development
Table 135. Novartis AG Company Details
Table 136. Novartis AG Business Overview
Table 137. Novartis AG Squamous Non-Small Cell Lung Cancer Therapeutics Product
Table 138. Novartis AG Revenue in Squamous Non-Small Cell Lung Cancer Therapeutics Business (2016-2021) & (US$ Million)
Table 139. Novartis AG Recent Development
Table 140. Oncogenex Pharmaceuticals, Inc. Company Details
Table 141. Oncogenex Pharmaceuticals, Inc. Business Overview
Table 142. Oncogenex Pharmaceuticals, Inc. Squamous Non-Small Cell Lung Cancer Therapeutics Product
Table 143. Oncogenex Pharmaceuticals, Inc. Revenue in Squamous Non-Small Cell Lung Cancer Therapeutics Business (2016-2021) & (US$ Million)
Table 144. Oncogenex Pharmaceuticals, Inc. Recent Development
Table 145. PsiOxus Therapeutics Limited Company Details
Table 146. PsiOxus Therapeutics Limited Business Overview
Table 147. PsiOxus Therapeutics Limited Squamous Non-Small Cell Lung Cancer Therapeutics Product
Table 148. PsiOxus Therapeutics Limited Revenue in Squamous Non-Small Cell Lung Cancer Therapeutics Business (2016-2021) & (US$ Million)
Table 149. PsiOxus Therapeutics Limited Recent Development
Table 150. Research Programs/Design for This Report
Table 151. Key Data Information from Secondary Sources
Table 152. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Squamous Non-Small Cell Lung Cancer Therapeutics Market Share by Type: 2020 VS 2027
Figure 2. BMS-906024 Features
Figure 3. Buparlisib Hydrochloride Features
Figure 4. FP-1039 Features
Figure 5. Ipilimumab Features
Figure 6. JNJ-42756493 Features
Figure 7. Lenvatinib Features
Figure 8. Others Features
Figure 9. Global Squamous Non-Small Cell Lung Cancer Therapeutics Market Share by Application: 2020 VS 2027
Figure 10. Research Center Case Studies
Figure 11. Hospital Case Studies
Figure 12. Clinic Case Studies
Figure 13. Squamous Non-Small Cell Lung Cancer Therapeutics Report Years Considered
Figure 14. Glob

• Clinical Results in Diabetics To Be Boosted By Smart Artificial Beta Cells

For a long time, the cure for diabetes type 1 and type 2 has relied on agonizing insulin shots for patients or insulin infusion via mechanical pumps. Regarding this, experts have been creating artificial pancreatic beta cells with the he…

• High-speed Data Transmission And High Volume Needs Propel Fiber Optic Connectors Market

Fiber optic connectors are a substantial fragment of the global telecommunication industry. Optical fibers are joined using fiber optic connectors, which allow the light conduction between two consecutive optical fibers. An additional im…

• Extensive Use of Digital Technologies for Diagnostic Applications To Boost Global Optical Imaging Market

The global optical imaging system market is predicted to reach US$ 3 billion by 2024. It is expected to grow at a stable rate and will post a CAGR of more than 8% in the coming years. The growing market infiltration of digital …

• Foremost Trends In Global Pet Care Market

The global pet care market is foretold to improve in the forthcoming years as matched to the preceding years and will showcase better sales in various market segments. It is estimated that the global pet care market will grow at a CAGR o…

• China To Review Its Food Security Laws

China has arisen as the globe’s firmest developing economy. In addition, China brags about the biggest population pool in the world. In recent times, the one child policy in the republic was terminated. This is anticipated to upsur…

Global Nuclear Medicine Cyclotron Systems Market Report, History and Forecast 2018-2029

Published: 11-Jan-2024        Price: US 3350 Onwards        Pages: 118

The global Nuclear Medicine Cyclotron Systems market was valued at US$ 220.85 million in 2022 and will reach US$ 283.75 million by the end of 2029, growing at a CAGR of 4.38% during 2023-2029. Asia-Pacific market for Nuclear Medicine Cyclotron Systems was valued at $ 61.16 million in 2022 and will reach $ 104.22 million by 2029, at a CAGR of 5.84% during the forecast period of 2023 through 2029. Report Scope This report aims to provide a comprehensive presentation of the glo......

Global Non-imaging Diagnostic Catheter Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 95

The global Non-imaging Diagnostic Catheter market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical drug market is estim......

Global Imaging Diagnostic Catheter Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 90

The global Imaging Diagnostic Catheter market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical drug market is estimated......

Global PCR Equipment Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 77

The global PCR Equipment market was valued at US$ 806 million in 2023 and is anticipated to reach US$ 1230.7 million by 2030, witnessing a CAGR of 6.7% during The forecast period 2024-2030. PCR (Polymerase Chain Reaction) equipment is widely used in molecular biology and genetics research for amplifying DNA and RNA sequences. The market for PCR equipment is influenced by several key drivers. Here are some of The significant market drivers: Advancements in Research and Diagnost......

Global Disposable Sterile Syringes and Needles Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 109

The global Disposable Sterile Syringes and Needles market was valued at US$ 404.4 million in 2023 and is anticipated to reach US$ 539.1 million by 2030, witnessing a CAGR of 2.1% during The forecast period 2024-2030. North American market for Disposable Sterile Syringes and Needles is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Disposable Sterile Syringes and N......

Global Orthopaedic Power Tools Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 106

The global Orthopaedic Power Tools market was valued at US$ 463.3 million in 2023 and is anticipated to reach US$ 746.5 million by 2030, witnessing a CAGR of 7.3% during The forecast period 2024-2030. North American market for Orthopaedic Power Tools is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Orthopaedic Power Tools is estimated to increase from $ million i......

Global Cerebrospinal Fluid Management Devices Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 86

The global Cerebrospinal Fluid Management Devices market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Cerebrospinal Fluid Management Devices is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Cerebrospinal Fluid Management Devices is estimate......

Global CAD & CAM Milling Burs Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 79

The global CAD & CAM Milling Burs market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for CAD & CAM Milling Burs is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for CAD & CAM Milling Burs is estimated to increase from $ million in 2023 to reach $ ......

Global Artificial Teeth Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 98

The global Artificial Teeth market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Artificial Teeth is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Artificial Teeth is estimated to increase from $ million in 2023 to reach $ million by 2030, a......

We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s. Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors. Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business. Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision. Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us. Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done. Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - [email protected] / +1 888 391 5441 )

• Ad Hoc
• Pay - as - you - go / Bucket Subscriptions
• Fixed Cost for #of reports
• Customize / Personalize as per your needs